Allecra Therapeutics
Novel antibiotics to combat drug-resistant bacterial infections
Allecra Therapeutics has raised €37M across 2 funding rounds from 4 investors, most recently a Series B round in Jun 2016. Based in Weil am Rhein, Germany; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€37M
€37,000,000
Funding rounds
2
Investors
4
distinct backers
Active since
2015-04
latest 2016-06
Funding by year
EUR raised per yearAllecra Therapeutics — funding by year — interactive chart.
Data table
| Allecra Therapeutics — funding by year | |
|---|---|
| 2015 | €15M |
| 2016 | €22M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-06-01 | Series B | €22M | Delos Capital,Edmond de Rothschild Venture Capital,EMBL Ventures,Forbion | View deal → |
| 2015-04-01 | Series A | €15M | Edmond de Rothschild Venture Capital,EMBL Ventures | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData